Heparin

Primary Uses

Heparin is primarily used to prevent and treat blood clots that can occur in the legs (deep vein thrombosis) or the lungs (pulmonary embolism). It is also used to manage blood clots associated with certain heart conditions, such as atrial fibrillation.

Medical Procedures

Healthcare providers often use heparin during or after specific medical procedures to reduce the risk of dangerous clotting. These situations include:

• Heart and blood vessel surgery.
• Kidney dialysis.
• Blood transfusions.
• Procedures involving extracorporeal circulation, such as using a heart-lung machine.

Other Applications

Heparin may be used in small amounts to prevent blood from clotting inside intravenous (IV) catheters that are left in the vein for a period of time. It is also used to treat certain blood clotting disorders, such as disseminated intravascular coagulation (DIC), and to prevent clots from forming in the blood vessels after a heart attack.

Mechanism of Action

Heparin is an anticoagulant, a type of medication commonly called a blood thinner. It works by interfering with the body's natural blood-clotting process to prevent the formation of harmful clots.

Inside the body, heparin binds to a protein called antithrombin III. This interaction speeds up the protein's ability to deactivate several enzymes that are essential for blood to clot, such as thrombin and Factor X. By blocking these enzymes, heparin prevents the conversion of certain blood components into fibrin, the material that forms the structure of a blood clot.

Heparin's primary functions include:

• Preventing new clots: It stops the clotting process before a blockage can form in the blood vessels.
• Stabilizing existing clots: Although heparin does not dissolve clots that are already present, it prevents them from becoming larger. This allows the body's natural systems to slowly break down the existing clot over time.

Common Side Effects

The most frequent side effects of heparin involve reactions at the injection site. These may include:

• Redness, pain, or mild bruising where the medicine was given.
• Temporary hair loss with long-term use.

Serious Side Effects

Heparin can cause serious bleeding or other severe reactions. Contact a healthcare provider immediately if you notice:

• Unusual bleeding, such as frequent nosebleeds, bleeding gums, or heavy menstrual bleeding.
• Signs of internal bleeding, including black or tarry stools, red or dark brown urine, or coughing up blood.
• Heparin-induced thrombocytopenia (HIT), a condition where platelet levels drop significantly, which may cause new blood clots to form.
• Severe allergic reactions, such as hives, skin rash, wheezing, or swelling of the face and throat.
• Skin necrosis, which appears as painful skin sores or purple patches, typically near the injection site.
• Symptoms of bone density loss (osteoporosis) if the medication is used for a long period.
• Fever or chills.

Bleeding Risks

The most serious risk associated with heparin is hemorrhage (severe bleeding). Bleeding can occur at almost any site in the body and may be fatal. The risk of bleeding is higher in the elderly, individuals with kidney or liver disease, and those with a history of gastrointestinal ulcers or recent surgery.

Heparin-Induced Thrombocytopenia (HIT)

Heparin can cause a serious immune-mediated reaction called heparin-induced thrombocytopenia (HIT), which is a significant drop in platelet counts. In some cases, this can lead to the development of new blood clots, a condition known as heparin-induced thrombocytopenia and thrombosis (HITT). Healthcare providers typically monitor platelet counts closely during treatment and will stop heparin immediately if HIT is suspected.

Contraindications

Heparin is generally not used in individuals with the following conditions:

• Severe or uncontrollable bleeding (except when caused by disseminated intravascular coagulation).
• A history of heparin-induced thrombocytopenia.
• Severe deficiency of platelets (thrombocytopenia).
• Known hypersensitivity to heparin or pork products, as most heparin is derived from pig intestines.

Medication Errors

There is a high risk of medication errors due to the wide range of available heparin concentrations. Fatalities have occurred when a high-concentration vial was mistaken for a low-concentration vial. Labels must be carefully checked before administration to ensure the correct dose is given.

Other Precautions

Heparin should be used with caution in people with high blood pressure, diabetes, or those who have recently undergone spinal or brain surgery. Some formulations contain benzyl alcohol as a preservative, which can cause serious side effects in premature infants and should be used with caution during pregnancy. Long-term use of heparin has also been associated with a risk of bone loss (osteoporosis).

Pregnancy

Heparin is frequently used to prevent or treat blood clots during pregnancy. Because heparin molecules are large, they do not cross the placenta and are not expected to harm the developing fetus. However, pregnant women using heparin should be aware of the following considerations:

• Preservatives: Some multi-dose vials of heparin contain benzyl alcohol as a preservative. This substance can cross the placenta and has been linked to serious complications in newborns. Preservative-free heparin is generally recommended for pregnant women.
• Bleeding Risks: There is an increased risk of maternal bleeding, particularly during labor and delivery. Healthcare providers will typically adjust or pause heparin treatment as the due date approaches to minimize this risk.
• Bone Health: Using heparin for an extended period during pregnancy may increase the risk of bone density loss (osteoporosis) in the mother.

Breastfeeding

Heparin is not excreted into human breast milk because of its high molecular weight. It is generally considered safe to use while breastfeeding, as it is unlikely to affect the nursing infant. As with any medication, patients should discuss the risks and benefits with their healthcare provider.

Dosage Forms

Heparin is supplied as a liquid solution for administration. It is not available in oral forms such as tablets or capsules. The primary forms include:

• Injectable Solution: A clear liquid used for subcutaneous injection or intravenous administration.
• Intravenous Infusion: Premixed solutions in flexible containers designed for continuous or intermittent infusion into a vein.
• Lock Flush Solution: A specific formulation used to maintain the patency of intravenous catheters and needles.

Heparin is packaged in several ways to accommodate different clinical needs, including single-dose vials, multi-dose vials, and prefilled syringes.

FDA Approval and Indications

Heparin is approved by the U.S. Food and Drug Administration (FDA) for several therapeutic and prophylactic uses. Its primary indications include:

• Prophylaxis and treatment of venous thrombosis and pulmonary embolism.
• Prevention of clotting in arterial and cardiac surgery.
• Treatment of peripheral arterial embolism.
• Management of atrial fibrillation with embolization.
• Diagnosis and treatment of disseminated intravascular coagulation (DIC).

It is also FDA-approved for use as an anticoagulant in extracorporeal circulation, dialysis procedures, and blood transfusions.

Regulatory History and Safety Oversight

Heparin has been in clinical use for decades. Due to its critical nature, the FDA maintains strict oversight of its manufacturing processes. In response to historical contamination issues, the FDA and the United States Pharmacopeia (USP) implemented enhanced testing standards to ensure the purity and potency of heparin products.

There is currently no Risk Evaluation and Mitigation Strategy (REMS) required for heparin. However, FDA-approved labeling includes significant warnings regarding the risk of heparin-induced thrombocytopenia (HIT), a serious immune-mediated reaction, and the potential for severe hemorrhage.

Reversing Heparin Effects

If a person receives too much heparin or experiences life-threatening bleeding, healthcare providers use a medication called protamine sulfate to neutralize its effects. This antidote works by binding directly to heparin in the bloodstream, which stops it from thinning the blood.

How the Antidote is Administered

Protamine sulfate is administered by medical professionals in a hospital setting. The process involves several key factors:

• Method: The antidote is given as a slow injection into a vein (intravenous).
• Dosing: The amount of protamine sulfate needed is calculated based on the dose of heparin received. Generally, 1 milligram of protamine sulfate neutralizes approximately 100 units of heparin.
• Timing: Because the body clears heparin relatively quickly, the amount of antidote required decreases as more time passes since the last heparin dose.

Healthcare providers monitor the patient closely during and after the administration of the antidote to ensure blood clotting returns to a safe level and to watch for potential side effects, such as a drop in blood pressure or allergic reactions.